“…In agreement with the exon definition model and the possible involvement of snRNPs in last exon definition, we have shown that components of the U1 snRNP function in polyadenylation+ We have previously demonstrated that the U1snRNP-A protein (U1A) can bind to the SV40 late polyadenylation signal (Lutz & Alwine, 1994), and that purified U1A can interact with a component of the polyadenylation complex, the 160 kDa subunit of cleavage-polyadenylation specificity factor (CPSF) (Lutz et al+, 1996)+ Using purified components (CPSF, poly(A) polymerase, and precleaved RNA) we have shown that the addition of purified bacterially expressed U1A caused a concentration-dependent increase in both the overall level of polyadenylation and in poly(A) tail length (Lutz et al+, 1996)+ In agreement with this result we have shown that the purified recombinant U1A stabilized the interaction of CPSF with the AAUAAA-containing substrate RNA+ It is important to emphasize that in both the in vitro polyadenylation and binding analyses the U1A protein functioned in a form which was free of other U1snRNP components+ We refer to this form as snRNP-free U1A, or SF-A+ Our previous in vitro data suggests that specific concentrations of SF-A can mediate a general enhancement of polyadenylation (Lutz et al+, 1996; O'Connor et al+, 1997)+ Other experiments have indicated that U1A can also mediate a very specific negative feedback regulatory mechanism affecting the polyadenylation of its own mRNA+ This involves specific interactions with both the pre-mRNA encoding U1A and poly(A) polymerase (Gunderson et al+, 1994(Gunderson et al+, , 1997)+ These findings raise the question of how much U1A protein is present as SF-A in the cell+ It has been assumed that most, if not all, of the cellular U1A protein is tightly bound to U1 RNA as part of the snRNP+ This assumption was based upon the high affinity (K d ; 10 Ϫ9 ) of U1A for U1 RNA (Lutz-Freyermuth et al+, 1990;Jessen et al+, 1991), and upon the negative autoregulation of polyadenylation of U1A's own message (Boelens et al+, 1993)+ Recently we demonstrated that at least two classes of U1A can be detected in human cell nucleoplasm: U1A that is associated with the U1snRNP, and SF-A that is complexed with a distinct set of non-snRNP proteins, that is, the SF-A complex(es) (O'Connor et al+, 1997)+ Based upon the quantitation of cellular levels of U1A (Baserga & Steitz, 1993) we estimated that approximately 3% of the total U1A protein in the cell is part of the SF-A complex+ This corresponds to approximately 30,000 molecules+ Our previous data also indicated that SF-A has a physiologically relevant function: specifically, an antibody which is specific for SF-A and not snRNP-bound U1A can inhibit in vitro polyadenylation of an SV40 late polyadenylation substrate RNA+ As mentioned above SF-A has been shown to be in complex(es) with other non-snRNP proteins (O'Connor et al+, 1997)+ In this article, we demonstrate (1) that the largest protein in the SF-A complex(es), p105, is PSF, the polypyrimidine-tract binding protein-associated splicing factor (Patton et al+, 1993); (2) that PSF interacts with U1A both in vitro and in vivo; and (3) that SF-A has effects on both splicing and polyadenylation in a coupled splicing and polyadenylation reaction...…”